BOOTLEGGED ECSTASY
JAMA March 7, 1964 DOI: 10.1001/jama.1964.03060230096025 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | LSD MDMA Psilocybin |
| Keywords | Gratification Pleasure Pimozide Publicity Hallucinogen Psychotherapist |
| Citations | 16 |
| Key findings | Research on LSD-25 and psilocybin has not provided clues to the etiology or therapy of natural psychoses, and the drugs' recreational use for gratification and social belonging has become an untoward byproduct. |
Abstract
For several years, quietly and without publicity, several scientists have been studying the behavioral pharmacology of lysergic acid diethylamide (LSD-25), and lately psilocybin, on experimental animals and human subjects. The psychotic effects of these drugs have some but not complete similarity to the schizophrenic psychoses, which has resulted in their classification as psychomimetics. Yet the study of their effects has not given a clue to the etiology or therapy of the naturally appearing psychoses, although a wealth of information regarding abnormal mental states has accrued. We are now confronted with two untoward byproducts which have no relation to legitimate scientific endeavors. The first is the widespread use of these drugs by irresponsible lay persons for their "kick" effect, for the gratification derived from vivid hallucinatory experience, and the pleasure of belonging to a "superior" social group which transcends the mundane existence of ordinary people. The second is the experimentation with
Comparable studies
Other narrative reviews on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Human Pharmacology of MDMA | 2004 | Review | |
| Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research | 2001 | Review | |
| 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans | 1994 | Review | |
| (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals | 2000 | Review | |
| Amphetamine toxicities | 2010 | Review |
Citations in the library
Cited by 3
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder The Canadian Journal of Psychiatry August 17, 2022
- The Varieties of Psychedelic Expertise in 1960s Canada: The Psychiatrists behind the Addiction Research Foundation's Study of LSD Therapy. Canadian journal of health history = Revue canadienne d'histoire de la sante April 1, 2023
- Equipoise and Personal Experience: Maintaining Objectivity in Psychedelic Research The American Journal of Bioethics 2025